Excitotoxicity-induced endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor

Journal of Neurochemistry

Volumn 119, Issue 6, 2011, Pages 1243-1252

  Vaslin, Anne ^a   Naegele Tollardo, Sonia ^a   Puyal, Julien ^a   Clarke, Peter G H ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

cell penetrating peptides; cerebral ischemia; neonatal stroke; NMDA receptors

Indexed keywords

ASPARTYLGLUTAMINYLSERYLARGINYLPROLYLVALYLGLUTAMINYLPROLYLPHENYLALANYLLEUCYLASPARAGINYLLEUCYLTHREONYLTHREONYLPROLYLARGINYLLYSYLPROLYLARGINYLPROLYLPROLYLARGINYLARGINYLARGINYLGLUTAMINYLARGINYLARGINYLLYSYLLYSYLARGINYLGLYCINE; D JNKI 1; N METHYL DEXTRO ASPARTIC ACID; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; XG 102;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENDOCYTOSIS; EXCITOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL NECROSIS; NEUROPROTECTION; NEWBORN; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; EXCITATORY AMINO ACID AGONISTS; INFARCTION, MIDDLE CEREBRAL ARTERY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; L-LACTATE DEHYDROGENASE; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDES; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

RATTUS;

EID: 82955168324     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07535.x     Document Type: Article

References (30)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J. W., Wang Y. T., Salter M. W., and, Tymianski M., (2002) Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298, 846-850. (Pubitemid 35231541)
2. Ashwal S., and, Pearce W. J., (2001) Animal models of neonatal stroke. Curr. Opin. Pediatr. 13, 506-516. (Pubitemid 34015520)
3. Bonny C., Oberson A., Negri S., Sauser C., and, Schorderet D. F., (2001) Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50, 77-82. (Pubitemid 32047984)
4. Borsello T., Bressoud R., Mottier V., Gonzalez N., Gomez G., and, Clarke P. G. H., (2003a) Kainate-induced endocytosis in retinal amacrine cells. J. Comp. Neurol. 465, 286-295. (Pubitemid 37100136)
5. Borsello T., Clarke P. G. H., Hirt L., Vercelli A., Repici M., Schorderet D. F., Bogousslavsky J., and, Bonny C., (2003b) A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9, 1180-1186. (Pubitemid 37173703)
6. Borsello T., Croquelois K., Hornung J. P., and, Clarke P. G. H., (2003c) N-methyl-d-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway. Eur. J. Neurosci. 18, 473-485. (Pubitemid 37041099)
7. Brecht S., Kirchhof R., Chromik A., et al. (2005) Specific pathophysiological functions of JNK isoforms in the brain. Eur. J. Neurosci. 21, 363-377. (Pubitemid 40204240)
8. Cardarelli F., Serresi M., Bizzarri R., Giacca M., and, Beltram F., (2007) In vivo study of HIV-1 Tat arginine-rich motif unveils its transport properties. Mol. Ther. 15, 1313-1322. (Pubitemid 46965328)
9. Centeno C., Repici M., Chatton J. Y., et al. (2007) Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons. Cell Death Differ. 14, 240-253. (Pubitemid 46092227)
10. Charriaut-Marlangue C., and, Renolleau S., (2006) Models for apoptosis: from newborn to adult, in Handbook of Models for Human Aging (, Conn P. M., ed.), pp. 521-532. Elsevier Academic Press, Burlington MA, USA, and London, UK.
11. Console S., Marty C., García-Echeverría C., Schwendener R., and, Ballmer-Hofer K., (2003) Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278, 35109-35114. (Pubitemid 37102274)
12. Eshraghi A. A., He J., Mou C. H., Polak M., Zine A., Bonny C., Balkany T. J., and, Van De Water T. R., (2006) D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma. Otol. Neurotol. 27, 504-511.
13. Esneault E., Castagne V., Moser P., Bonny C., and, Bernaudin M., (2008) D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats. Neuroscience 152, 308-320.
14. Ferriero D. M., (2004) Neonatal brain injury. N. Engl. J. Med. 351, 1985-1995.
15. Fonseca S. B., Pereira M. P., and, Kelley S. O., (2009) Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv. Drug Deliv. Rev. 61, 953-964.
16. Ginsberg M. D., (2008) Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55, 363-389.
17. Guan Q. H., Pei D. S., Zong Y. Y., Xu T. L., and, Zhang G. Y., (2006) Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 139, 609-627.
18. Guegan C., Braudeau J., Couriaud C., Dietz G. P., Lacombe P., Bahr M., Nosten-Bertrand M., and, Onteniente B., (2006) PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms. Neurobiol. Dis. 22, 177-186.
19. Hagberg H., Ichord R., Palmer C., Yager J. Y., and, Vannucci S. J., (2002) Animal models of developmental brain injury: relevance to human disease. A summary of the panel discussion from the Third Hershey Conference on Developmental Cerebral Blood Flow and Metabolism. Dev. Neurosci. 24, 364-366. (Pubitemid 36359367)
20. Hirt L., Badaut J., Thevenet J., Granziera C., Regli L., Maurer F., Bonny C., and, Bogousslavsky J., (2004) D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke 35, 1738-1743. (Pubitemid 38823657)
21. Kuan C. Y., Whitmarsh A. J., Yang D. D., et al. (2003) A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl. Acad. Sci. USA 100, 15184-15189. (Pubitemid 37518037)
22. Oeschger F., Vaslin A., Coffey E. T., Clarke P.G.H., and, Puyal J., (2008) Subcellular targeting of c-jun N-terminal kinase (JNK) inhibition in normal and excitotoxic conditions. FENS Abstr. 4, 184. 43.
23. Puyal J., Vaslin A., Mottier V., and, Clarke P. G. H., (2009) Postischemic treatment of neonatal cerebral ischemia should target autophagy. Ann. Neurol. 66, 378-389.
24. Rao K. S., Reddy M. K., Horning J. L., and, Labhasetwar V., (2008) TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29, 4429-4438.
25. Soriano F. X., Martel M. A., Papadia S., et al. (2008) Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J. Neurosci. 28, 10696-10710.
26. Strbian D., Durukan A., Pitkonen M., Marinkovic I., Tatlisumak E., Pedrono E., Abo-Ramadan U., and, Tatlisumak T., (2008) The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153, 175-181.
27. Vaslin A., Puyal J., Borsello T., and, Clarke P. G. H., (2007) Excitotoxicity-related endocytosis in cortical neurons. J. Neurochem. 102, 789-800. (Pubitemid 47057282)
28. Vaslin A., Puyal J., and, Clarke P. G. H., (2009) Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia. Ann. Neurol. 65, 337-347.
29. Wiegler K., Bonny C., Coquoz D., and, Hirt L., (2008) The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator. Cerebrovasc. Dis. 26, 360-366.
30. Yang D. D., Kuan C. Y., Whitmarsh A. J., Rincon M., Zheng T. S., Davis R. J., Rakic P., and, Flavell R. A., (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870. (Pubitemid 27462982)